checkAd

     149  0 Kommentare Oncolytics Biotech Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors - Seite 4

    Company Contact

    Kirk Look

    Chief Financial Officer

    +1-403-670-7658

    KLook@oncolytics.ca

    Investor Relations for Oncolytics

    Timothy McCarthy

    LifeSci Advisors

    +1-917-679-9282

    tim@lifesciadvisors.com

     

    Lesen Sie auch


    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 4 von 4

    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Oncolytics Biotech Reports Preclinical Data Demonstrating the Synergistic Anti-cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors - Seite 4 Mayo Clinic shows pelareorep vastly improved persistence and efficacy of CAR T cell therapy leading to cures in this model Pelareorep's synergistic effects with CAR T therapy appear to be specific and were not observed with the oncolytic virus VSV …